+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immunoprotein Market by Product, Application, End User, Technology, Distribution Channel - Global Forecast to 2030- Product Image
Immunoprotein Market by Product, Application, End User, Technology, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Immunoprotein Market by Product, Application, End User, Technology, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5532790
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The immunoprotein market stands at a pivotal juncture, with advanced analytics, product innovation, and regulatory shifts rapidly transforming how key healthcare stakeholders leverage immunoproteins for both diagnostics and therapy. Senior decision-makers are under increasing pressure to anticipate emerging trends and realign resources efficiently as immunoproteins evolve into indispensable components across global healthcare systems.

Market Snapshot: Immunoprotein Market Overview

The immunoprotein market grew from USD 21.54 billion in 2024 to USD 23.81 billion in 2025 and is projected to reach USD 38.72 billion by 2030, representing a CAGR of 10.26%. This robust expansion reflects the market’s shift from specialized use toward widespread clinical integration across autoimmune, hematological, and immunodeficiency disorder management. Market growth is further propelled by a maturing understanding of immunoprotein applications, increased patient demand for both diagnostic and therapeutic solutions, and the normalization of precision diagnostics within healthcare delivery models.

Scope & Segmentation of the Immunoprotein Market

  • Product Types: Intramuscular immunoglobulin (standard), intravenous immunoglobulin (branded, generic, hypoimmune, next generation), and subcutaneous immunoglobulin (conventional, facilitated)
  • Applications: Diagnostic uses (disease marker detection, immune response assessment, pharmacokinetic studies) and therapeutic uses (autoimmune, hematological, immunodeficiency, infectious, and neurological disorders)
  • End User Settings: Diagnostic centers, home healthcare settings, hospitals, research laboratories, specialty clinics
  • Technologies: Capillary electrophoresis, enzyme linked immunosorbent assay, liquid chromatography mass spectrometry, protein microarray, surface plasmon resonance
  • Distribution Channels: Direct sales, distributor sales, hospital pharmacies, online sales, retail pharmacies
  • Regions Covered: Americas (with coverage of United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, and others), Asia-Pacific (notably China, India, Japan, Australia, and several Southeast Asian countries)
  • Key Companies Profiled: CSL Limited, Grifols S.A., Takeda Pharmaceutical Company Limited, Octapharma AG, Baxter International Inc., Kedrion S.p.A., LFB Group, Biotest AG, Japan Blood Products Organization, Sanquin Blood Supply Foundation

Key Takeaways for Senior Decision-Makers

  • Product innovation is rising, with next-generation and hypoimmune formulations broadening treatment options and catering to specialized patient groups.
  • Convergence with digital health and real-world evidence frameworks is improving both product validation and patient engagement, establishing a new standard for market entrants and incumbents.
  • Regional growth trajectories diverge, with the Americas and Western Europe benefiting from robust biopharmaceutical ecosystems, while Asia-Pacific accelerates investment, expanding both diagnostic and therapeutic capacity.
  • Strategic alliances between biopharmaceutical companies and technology providers are becoming critical levers for cost management and regulatory advantage, particularly when combining analytics with flexible manufacturing models.
  • End user demand is being redefined by home healthcare adoption, shifting procurement dynamics and increasing demand for facilitated and home-administered immunoglobulin products.

Tariff Impact in the Immunoprotein Market

The implementation of new tariffs in 2025 has significantly affected sourcing and manufacturing costs for immunoproteins, especially raw materials and finished products imported from primary production hubs. These cost adjustments are prompting more companies to invest locally and strengthen supply chain resilience via strategic stockpiling and diversified logistics networks. Shifts in regional sourcing and tariff-driven manufacturing realignment are especially pertinent for executive teams managing global portfolios.

Immunoprotein Market Methodology & Data Sources

This market study draws on expert interviews, secondary data from peer-reviewed literature, regulatory filings, and corporate disclosures. A cross-validation process reconciles sources for data integrity, and segmentation frameworks are refined through discussions with subject matter experts. Regional insights are contextualized with macroeconomic and demographic analysis to ground market projections and opportunity assessment.

Why This Report Matters for Executives

  • Informs agile resource allocation and supply chain strategies to address tariff risk and ensure uninterrupted immunoprotein delivery.
  • Guides portfolio optimization by pinpointing high-growth application areas and identifying technology partnerships that drive value and compliance.
  • Delivers insight into how evolving reimbursement and patient-centric models are shaping procurement and uptake across clinical environments.

Conclusion

Senior leaders who leverage nuanced segmentation and anticipate regulatory trends are best positioned to drive resilient growth in the immunoprotein market. Aligning operational decision-making with evolving technology and regional dynamics will be essential to unlocking long-term market value and advancing patient care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Immunoprotein Market, by Product
8.1. Introduction
8.2. Intramuscular Immunoglobulin
8.2.1. Standard
8.3. Intravenous Immunoglobulin
8.3.1. Branded
8.3.2. Generic
8.3.3. Hypoimmune
8.3.4. Next Generation
8.4. Subcutaneous Immunoglobulin
8.4.1. Conventional
8.4.2. Facilitated
9. Immunoprotein Market, by Application
9.1. Introduction
9.2. Diagnostic
9.2.1. Disease Marker Detection
9.2.2. Immune Response Assessment
9.2.3. Pharmacokinetic Studies
9.3. Therapeutic
9.3.1. Autoimmune Disorders
9.3.2. Hematological Disorders
9.3.3. Immunodeficiency Disorders
9.3.4. Infectious Diseases
9.3.5. Neurological Disorders
10. Immunoprotein Market, by End User
10.1. Introduction
10.2. Diagnostic Centers
10.3. Home Healthcare Settings
10.4. Hospitals
10.5. Research Laboratories
10.6. Specialty Clinics
11. Immunoprotein Market, by Technology
11.1. Introduction
11.2. Capillary Electrophoresis
11.3. Enzyme Linked Immunosorbent Assay
11.4. Liquid Chromatography Mass Spectrometry
11.5. Protein Microarray
11.6. Surface Plasmon Resonance
12. Immunoprotein Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributor Sales
12.4. Hospital Pharmacies
12.5. Online Sales
12.6. Retail Pharmacies
13. Americas Immunoprotein Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Immunoprotein Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Immunoprotein Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. CSL Limited
16.3.2. Grifols, S.A.
16.3.3. Takeda Pharmaceutical Company Limited
16.3.4. Octapharma AG
16.3.5. Baxter International Inc.
16.3.6. Kedrion S.p.A.
16.3.7. LFB Group
16.3.8. Biotest AG
16.3.9. Japan Blood Products Organization
16.3.10. Sanquin Blood Supply Foundation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. IMMUNOPROTEIN MARKET MULTI-CURRENCY
FIGURE 2. IMMUNOPROTEIN MARKET MULTI-LANGUAGE
FIGURE 3. IMMUNOPROTEIN MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL IMMUNOPROTEIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. IMMUNOPROTEIN MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. IMMUNOPROTEIN MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. IMMUNOPROTEIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IMMUNOPROTEIN MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY STANDARD, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY BRANDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY HYPOIMMUNE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY NEXT GENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY FACILITATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY DISEASE MARKER DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY IMMUNE RESPONSE ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PHARMACOKINETIC STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY IMMUNODEFICIENCY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY HOME HEALTHCARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY LIQUID CHROMATOGRAPHY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PROTEIN MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY SURFACE PLASMON RESONANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 73. CANADA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. CANADA IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 75. CANADA IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 76. CANADA IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 77. CANADA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. CANADA IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 79. CANADA IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 80. CANADA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. CANADA IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. CANADA IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. MEXICO IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. MEXICO IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 85. MEXICO IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 86. MEXICO IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 87. MEXICO IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. MEXICO IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 89. MEXICO IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 90. MEXICO IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. MEXICO IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. MEXICO IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 128. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 130. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. GERMANY IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. GERMANY IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 136. GERMANY IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 137. GERMANY IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 138. GERMANY IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. GERMANY IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 140. GERMANY IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 141. GERMANY IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. GERMANY IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. GERMANY IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. FRANCE IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. FRANCE IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 146. FRANCE IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 147. FRANCE IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 148. FRANCE IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. FRANCE IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 150. FRANCE IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 151. FRANCE IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. FRANCE IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. FRANCE IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. ITALY IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. ITALY IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 166. ITALY IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 167. ITALY IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 168. ITALY IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. ITALY IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 170. ITALY IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 171. ITALY IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. ITALY IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. ITALY IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. SPAIN IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. SPAIN IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 176. SPAIN IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 177. SPAIN IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 178. SPAIN IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. SPAIN IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 180. SPAIN IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 181. SPAIN IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. SPAIN IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. SPAIN IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 210. SOUTH AFRICA IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. SOUTH AFRICA IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 214. DENMARK IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 215. DENMARK IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 216. DENMARK IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 217. DENMARK IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 218. DENMARK IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. DENMARK IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 220. DENMARK IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 221. DENMARK IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. DENMARK IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 223. DENMARK IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. NETHERLANDS IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 225. NETHERLANDS IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 227. NETHERLANDS IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. QATAR IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 235. QATAR IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 236. QATAR IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 237. QATAR IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 238. QATAR IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. QATAR IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 240. QATAR IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 241. QATAR IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. QATAR IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 243. QATAR IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. FINLAND IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 245. FINLAND IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 246. FINLAND IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 247. FINLAND IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 248. FINLAND IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. FINLAND IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 250. FINLAND IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 251. FINLAND IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. FINLAND IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 253. FINLAND IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. SWEDEN IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 260. SWEDEN IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 261. SWEDEN IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. SWEDEN IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 263. SWEDEN IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 264. NIGERIA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 265. NIGERIA IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 266. NIGERIA IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 267. NIGERIA IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 268. NIGERIA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. NIGERIA IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 270. NIGERIA IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 271. NIGERIA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. NIGERIA IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 273. NIGERIA IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 274. EGYPT IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 275. EGYPT IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 276. EGYPT IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 277. EGYPT IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 278. EGYPT IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. EGYPT IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 280. EGYPT IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 281. EGYPT IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. EGYPT IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 283. EGYPT IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 284. TURKEY IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 285. TURKEY IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 286. TURKEY IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 287. TURKEY IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 288. TURKEY IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. TURKEY IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 290. TURKEY IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 291. TURKEY IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. TURKEY IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 293. TURKEY IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 294. ISRAEL IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 295. ISRAEL IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 296. ISRAEL IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 297. ISRAEL IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 298. ISRAEL IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. ISRAEL IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 300. ISRAEL IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 301. ISRAEL IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. ISRAEL IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 303. ISRAEL IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 304. NORWAY IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 305. NORWAY IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 306. NORWAY IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 307. NORWAY IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 308. NORWAY IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 309. NORWAY IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 310. NORWAY IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 311. NORWAY IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 312. NORWAY IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 313. NORWAY IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 314. POLAND IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 315. POLAND IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 316. POLAND IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 317. POLAND IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 318. POLAND IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 319. POLAND IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 320. POLAND IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 321. POLAND IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 322. POLAND IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 323. POLAND IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 324. SWITZERLAND IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 325. SWITZERLAND IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 326. SWITZERLAND IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 327. SWITZERLAND IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 328. SWITZERLAND IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 329. SWITZERLAND IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 330. SWITZERLAND IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 331. SWITZERLAND IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 332. SWITZERLAND IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 333. SWITZERLAND IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 334. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 335. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 336. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 337. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 338. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 339. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 340. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 341. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 342. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 343. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 344. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 345. CHINA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 346. CHINA IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 347. CHINA IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 348. CHINA IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 349. CHINA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 350. CHINA IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 351. CHINA IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 352. CHINA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 353. CHINA IMMUNOPROTEIN MARKET SIZE,

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Immunoprotein market report include:
  • CSL Limited
  • Grifols, S.A.
  • Takeda Pharmaceutical Company Limited
  • Octapharma AG
  • Baxter International Inc.
  • Kedrion S.p.A.
  • LFB Group
  • Biotest AG
  • Japan Blood Products Organization
  • Sanquin Blood Supply Foundation

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 23.81 Billion
Forecasted Market Value ( USD ) by 2030 $ 38.72 Billion
Compound Annual Growth Rate10.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Immunoprotein Diagnostic Testing Market Size, Share & Trends Analysis Report By Test (Immunoglobulin Diagnostic Tests), By Technology, By Application, By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Immunoprotein Diagnostic Testing Market Size, Share & Trends Analysis Report By Test (Immunoglobulin Diagnostic Tests), By Technology, By Application, By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 180 Pages
  • Global
From
Immunoprotein Diagnostic Testing Market by Assay Type, Technology, End User, Application, Sample Type - Global Forecast to 2030 - Product Image

Immunoprotein Diagnostic Testing Market by Assay Type, Technology, End User, Application, Sample Type - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Immunoprotein Diagnostic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Immunoprotein Diagnostic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Immunoprotein Diagnostic Testing - Global Strategic Business Report - Product Image

Immunoprotein Diagnostic Testing - Global Strategic Business Report

  • Report
  • 171 Pages
  • Global
From
2024 POC/Decentralized Clinical Chemistry and Immunodiagnostic Testing Market: Country Supplier Shares, Test Volume and Sales Segment Forecasts - Product Image

2024 POC/Decentralized Clinical Chemistry and Immunodiagnostic Testing Market: Country Supplier Shares, Test Volume and Sales Segment Forecasts

  • Report
  • Global
From

About the Immunoprotein Market

The Immunoprotein market within the In Vitro Diagnostics (IVD) industry is a rapidly growing sector. It is used to detect and measure the presence of antigens and antibodies in a patient's sample. Immunoprotein tests are used to diagnose a variety of conditions, including autoimmune diseases, allergies, infections, and cancer. These tests are also used to monitor the effectiveness of treatments. Immunoprotein tests are typically performed in a laboratory setting, and the results are used to inform clinical decisions. The tests are highly sensitive and specific, and they can be used to detect even small amounts of antigens or antibodies. The Immunoprotein market is expected to continue to grow as more tests become available and as the demand for IVD tests increases. This growth is driven by the increasing prevalence of chronic diseases, the need for more accurate and timely diagnosis, and the development of new technologies. Some of the major players in the Immunoprotein market include Abbott Laboratories, Bio-Rad Laboratories, Siemens Healthineers, Roche Diagnostics, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.